Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, Massachusetts
- Most recent report
- 8-K, filed Aug 10, 2026
- Incorporated
- Delaware
- Filings on record
- 223 filings
- On EDGAR
- CIK 2036042
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 7
News 8 of 12
Prospectuses and Registrations 6
- S-8 Registration statement for an employee plan Mar 2, 2026
- S-3ASR Automatic shelf registration Mar 2, 2026
- S-8 Registration statement for an employee plan Feb 7, 2025
- 424B4 Final prospectus for an offering Feb 7, 2025
- S-1/A Registration statement for an offering, amended Feb 3, 2025
- S-1 Registration statement for an offering Jan 17, 2025
Proxies 4
Ownership 8 of 177
- 4 Insider reported a trade Jul 9, 2026
- 4 Insider reported a trade Jul 9, 2026
- 4 Insider reported a trade Jul 7, 2026
- 144 Notice of a proposed sale of restricted stock Jul 6, 2026
- 4 Insider reported a trade Jul 2, 2026
- 4 Insider reported a trade Jul 2, 2026
- 4 Insider reported a trade Jun 18, 2026
- 4 Insider reported a trade Jun 18, 2026
Other 8 of 17
- ARS Annual report sent to shareholders Apr 27, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- SEC STAFF LETTER Feb 6, 2025
- EFFECT Notice that a registration became effective Feb 6, 2025
- S-1MEF Feb 6, 2025
- CERT Exchange certified a listing Feb 6, 2025
- 8-A12B Registration of a security for exchange listing Feb 4, 2025
- CORRESP Reply to SEC staff Feb 4, 2025
Everything here comes from Sionna Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.